Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Lastest Acne Alternative News

Posted Oct 29 2010 7:06pm

< p>Guide to Springfield – The Simpsons
Acne Alternative
Image by TheCamerons
Check out my blog

Cipher completes enrolment in CIP-ISOTRETINOIN Phase III study for severe, nodular acne
Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company’s novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).
Read more on

Contraceptive gel could offer alternative to pill
Women in gel trials report no side effects often associated with the pill, such as weight gain and acne A new contraceptive gel that is applied directly to the skin could offer women an alternative to the pill, a study suggests. The clear gel is put on once a day and delivers a dose of hormones to prevent pregnancy. Women using the gel have reported none of the typical side effects associated …
Read more on

CIPHER PHARMACEUTICALS COMPLETES PATIENT ENROLMENT IN CIP-ISOTRETINOIN PHASE III SAFETY STUDY
Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON , Oct. 29 /PRNewswire-FirstCall/ – Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company’s novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under …
Read more on

Cipher Pharmaceuticals Completes Patient Enrolment in Cip-Isotretinoin Phase III Safety Study
Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON , Oct. 29 /PRNewswire-FirstCall/ – Cipher Pharmaceuticals Inc. (TSX: DND.to – News ) today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company’s novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being …
Read more on

Post a comment
Write a comment:

Related Searches